Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration

• Главные авторы: Shujuan Zhao (Автор), Xuejiao Hong (Автор), Jingjing Cao (Автор), Haixia Cai (Автор), Song Du (Автор), Peizhi Ma (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2020-08-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Patients with non-valvular atrial fibrillation (NVAF) exhibit a high risk of stroke, which is associated with high mortality. Thus, stroke prevention is crucial for the overall management of NVAF. Two categories of drugs, vitamin K antagonist warfarin and non-vitamin K antagonist oral anticoagulants...